Showing results for "#DCGI"
'52% Indian families have had 1 member face unknown side effects from...
The report revealed that 18 per cent families surveyed had one or more members who experienced unknown side effects thrice or more in the last 5 years
DCGI gives nod to India's first indigenous mRNA vaccine for human...
India's first indigenous mRNA vaccine candidate has received approval from the Drug Controller General of India to initiate Phase I/II human clinical...
DCGI Approves Serum, Bharat Biotech Vaccine For Emergency Use
Vaccines of Serum Institue of India and Bharat Biotech are granted permission for restricted use in the emergency situation said DCGI in a press...
DCGI To Brief Media Today On Covid-19 Vaccine
The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
DCGI extends shelf life of Covishield from 6 to 9 months
India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its...
Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin
Bharat Biotech has written to the India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin...
DCGI approves DRDO's anti-COVID drug for emergency use
The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS)...
Zydus seeks DCGI approval for clinical trial of monoclonal antibodies...
Zydus Cadila on Thursday announced that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can...
